Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Person › Details

John McHutchison (Gilead Sciences Inc. (Nasdaq: GILD))

McHutchison, John (Gilead 201809 CSO)

 

Organisation Organisation Gilead Sciences Inc. (Nasdaq: GILD)
  Group Gilead Sciences (Group)
Products Product pharmaceutical
  Product 2 drug development
Document Source Galapagos N.V.. (9/11/18). "Press Release: Gilead and Galapagos Announce Filgotinib Meets Primary and All Key Secondary Endpoints in First Phase 3 Study in Rheumatoid Arthritis". Foster City, CA & Mechelen.
     

   
Record changed: 2019-07-23

Advertisement

Picture [iito] Plain Stupid Simple 650x80px


More documents for John McHutchison


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [iito] Back into Ad 650x80px




» top